The Technical Analyst
Movano Inc. [MOVE]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Movano Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.81% $0.485
America/New_York / 25 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 24.62 mill |
| EPS: | -0.770 |
| P/E: | -0.630 |
| Earnings Date: | N/A |
| SharesOutstanding: | 50.81 mill |
| Avg Daily Volume: | 0.232 mill |
| RATING 2024-04-25 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | ||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.630 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.630 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$0.313 (-35.42%) $-0.172 |
| Date: 2024-04-25 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.424 - 0.546 ( +/- 12.59%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-02 | Caballero Ruben | Buy | 22 000 | Common Stock |
| 2024-04-02 | Caballero Ruben | Buy | 22 000 | Warrant to Purchase Common Stock |
| 2024-04-02 | Cogan Jeremy | Buy | 45 000 | Common Stock |
| 2024-04-02 | Cogan Jeremy | Buy | 45 000 | Warrant to Purchase Common Stock |
| 2024-04-02 | Cullinan Brian | Buy | 44 000 | Common Stock |
| INSIDER POWER |
|---|
| 100.00 |
| Last 95 transactions |
| Buy: 13 492 299 | Sell: 2 224 708 |
Forecast:
16:00 - $0.485
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.485
Forecast 2: 16:00 - $0.485
Forecast 3: 16:00 - $0.485
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.485 (1.81% ) |
| Volume | 0.0121 mill |
| Avg. Vol. | 0.232 mill |
| % of Avg. Vol | 5.21 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MOVE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MOVE
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company develops Movano Ring that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is also developing non-invasive continuous glucose monitoring and cuffless blood pressure monitoring features to its technology platform. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
Last 10 Buy Signals
Latest Press Releases
2024-04-05 08:00:00 - Press Release
Movano Health Closes $24 Million Private Placement
Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from insiders including members of movano health's management team and board of directors pleasanton, calif. , april 5, 2024 /prnewswire/ -- movano health (nasdaq: move), a pioneer in health technology, has closed on a $24.1 million private placement, totaling 45.3 million units, with each unit consisting of one share of the company's common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that includes a tier-one multi-billion dollar medical device company, institutional and accredited investors, and members of the company's management team and board of directors.
2024-04-04 16:30:00 - Press Release
Movano Health Reports 2023 Financial Results And Provides Business Update
Executes $24 million funding extending cash runway focuses on 2024 strategic pathway to fda clearances driving b2b opportunities plans launch of evie med conference call at 2:00 pm pt/ 5:00 pm et today pleasanton, calif. , april 4, 2024 /prnewswire/ -- movano health (nasdaq: move), a pioneer in health technology, reported fourth quarter and year end 2023 results and provided a business update.
2024-04-02 17:01:00 - Press Release
Movano Health Announces $24 Million Private Placement
Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from members of movano health's management team and board of directors hosting conference call on april 4, 2024 at 2:00 pm pt/5:00 pm et pleasanton, calif. , april 2, 2024 /prnewswire/ -- movano health (nasdaq: move), a pioneer in health technology, today has agreed to sell approximately 45 million units in a $24 million private placement, with each unit consisting of one share of the company's common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that includes a tier-one multi-billion dollar medical device company, institutional and accredited investors, and members of the company's management team and board of directors.
2024-04-02 17:00:00 - Press Release
Movano Health Secures Strategic Investment From Tier-one Multi-billion Dollar Medical Device Company
The seed investment and agreement underscores movano health's multi-analyte and proprietary mmwave radio frequency technology pleasanton, calif. , april 2, 2024 /prnewswire/ -- movano health (nasdaq: move), a pioneer in health technology, secured a strategic investment from a tier-one multi-billion dollar medical device company and signed an agreement to explore future collaborations relating to development and commercialization.
2024-04-02 16:05:00 - Press Release
Movano Health To Report Fourth Quarter 2023 Financial Results On Thursday, April 4, 2024
Conference call at 2:00 pm pt/ 5:00 pm et pleasanton, calif. , april 2, 2024 /prnewswire/ -- movano health (nasdaq: move), a pioneer in health technology, today announced that it will report fourth quarter 2023 financial and operating results on thursday, april 4, 2024, after the market close.
Latest News
2023-11-15 17:25:24 - Seeking Alpha
Movano Inc. (MOVE) Q3 2023 Earnings Call Transcript
Movano Inc. (NASDAQ:MOVE ) Q3 2023 Earnings Conference Call November 15, 2023 11:30 AM ET Company Participants Jay Cogan - Chief Financial Officer John Mastrototaro - Chief Executive Officer Tyler Bucher - Chief Marketing Officer Michael Leabman - Founder and Chief Technology Officer Stacy Salvi - Vice President, Product and Strategy Operator Hello and welcome to Movano Health Third Quarter 2023 Earnings Call. I'd like to remind everyone that this call is being recorded and a replay of the call will be available on Movano Health's website, ir.movano.com.
2023-11-14 16:15:00 - PRNewsWire
Movano Inc. to Report Third Quarter 2023 Financial Results on Wednesday, November 15, 2023
Reschedules Q3 results conference call to 11:30 am EST on November 15, 2023 PLEASANTON, Calif. , Nov. 14, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring , today announced that, in light of the Company's recently announced proposed common stock offering, Movano Health has issued its Form 10-Q for the third quarter of 2023 and will report third quarter 2023 financial and operating results on Wednesday, November 15, 2023, before the equity markets open.
2023-11-03 16:05:00 - PRNewsWire
Movano Inc. to Report Third Quarter 2023 Financial Results Tuesday, November 14, 2023
PLEASANTON, Calif. , Nov. 3, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it will report third quarter 2023 financial and operating results on Tuesday, November 14, 2023.
2023-08-15 00:05:09 - Seeking Alpha
Movano Inc. (MOVE) Q2 2023 Earnings Call Transcript
Movano Inc. (NASDAQ:MOVE ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Jeremy Cogan - CFO & Secretary John Mastrototaro - CEO, President & Director Michael Aaron Leabman - Founder, CTO & Director Tyla Bucher - Chief Marketing Officer Conference Call Participants Marie Thibault - B. Riley Operator Greetings and welcome to the Movano Second Quarter 2023 Earnings Call.
2023-08-08 16:30:00 - PRNewsWire
Movano Inc. to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
PLEASANTON, Calif. , Aug. 8, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it will report second quarter 2023 financial and operating results on Monday, August 14, 2023.
2023-05-15 14:19:01 - Seeking Alpha
Movano Inc. (MOVE) Q1 2023 Earnings Call Transcript
Movano Inc. (NASDAQ:MOVE ) Q1 2023 Earnings Conference Call May 15, 2023 12:00 PM ET Company Participants J. Cogan – Chief Financial Officer John Mastrototaro – Chief Executive Officer Tyla Bucher – Chief Marketing Officer Stacy Salvi – Vice President of Strategy Michael Leabman – Founder and Chief Technology Officer Conference Call Participants Operator Greetings, and welcome to Movano's First Quarter 2023 Earnings Call.
2023-03-20 14:44:06 - Seeking Alpha
Movano Inc. (MOVE) Q4 2022 Earnings Call Transcript
Movano Inc. (NASDAQ:MOVE ) Q4 2022 Earnings Conference Call March 20, 2023 12:00 PM ET Company Participants J. Cogan - Chief Financial Officer John Mastrototaro - Chief Executive Officer Tyla Bucher - Chief Marketing Officer Michael Leabman - Founder and Chief Technology Officer Stacy Salvi - Vice President of Strategy Conference Call Participants Bruce Jackson - The Benchmark Company Operator Hello, and welcome to Movano Health Fourth Quarter 2022 Earnings Call.
2022-12-28 07:00:57 - TechCrunch
Movano's new smart ring is focused on women's health
Movano's getting a week's jump on what might well prove a banner CES for the smart ring. Today the Bay Area-based firm debuted Evie, a smart ring focused on women's health set to hit the market later next year.
2022-11-14 19:14:06 - Seeking Alpha
Movano Inc. (MOVE) Q3 2022 Earnings Call Transcript
Movano Inc. (NASDAQ:MOVE ) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants J. Cogan – Chief Financial Officer John Mastrototaro – Chief Executive Officer Stacy Salvi – Vice President of Strategy Conference Call Participants Marie Thibault – BTIG Operator Greetings.
2022-08-15 22:40:55 - Seeking Alpha
Movano Inc. (MOVE) CEO John Mastrototaro on Q2 2022 Results - Earnings Call Transcript
Movano Inc. (NASDAQ:MOVE ) Q2 2022 Earnings Conference Call August 17, 2022 5:00 PM ET Company Participants John Mastrototaro - CEO J. Cogan - CFO Michael Leabman - CTO Conference Call Participants Operator Greeting and welcome to the Movano Second Quarter 2022 Earnings Call.